Synthesis and pharmacological activity of some 2,3-dihydrofuran-2,3-dione derivatives. 1982

W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska

New 2,3-dihydrofuran-2,3-dione derivatives (1-11) were obtained by condensation of oxalyl chloride with Schiff bases of acetyl- or benzoylacetone and aromatic amines. These compounds showed only weak sedative action and weak analgesic effect.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006591 Hexobarbital A barbiturate that is effective as a hypnotic and sedative. Evipan,Hexenal,Hexobarbitone,Sodium Hexobarbital,Hexobarbital, Sodium
D006916 5-Hydroxytryptophan The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant. 5-HTP,Hydroxytryptophan,Oxitriptan,Oxytryptophan,Tryptophan, 5-Hydroxy-,5 Hydroxytryptophan,5-Hydroxy- Tryptophan,Tryptophan, 5 Hydroxy
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
September 2007, Bioorganic & medicinal chemistry,
W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
October 2000, Bioorganic & medicinal chemistry letters,
W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
June 1965, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft,
W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
November 1970, Il Farmaco; edizione scientifica,
W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
October 1995, Farmaco (Societa chimica italiana : 1989),
W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
January 2005, Arzneimittel-Forschung,
W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
January 2009, Arzneimittel-Forschung,
W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
September 1987, Bollettino della Societa italiana di biologia sperimentale,
W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
November 1981, Il Farmaco; edizione scientifica,
W Zankowska-Jasińska, and M Burgieł, and J Golus, and A Kolasa, and K Walocha, and B Zaleska, and E Chojnacka-Wójcik, and B Wiczyńska, and E Tatarczyńska
November 1997, The Journal of organic chemistry,
Copied contents to your clipboard!